Rating History for Amneal Pharmaceuticals (AMRX) by Leerink
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/9/2026 | Daniel Clark | New Coverage | Outperform (N/A) |
23.00 (N/A) |
17.05 (16.87) |
-1.06% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/9/2026 | Daniel Clark | New Coverage | Outperform (N/A) |
23.00 (N/A) |
17.05 (16.87) |
-1.06% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||